Uncover key drivers, emerging technologies, and competitive movements shaping the immune response testing market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Immune Response Testing Market?

The immune response testing market has seen rapid expansion in recent years. Its valuation is set to increase from $14.77 billion in 2024 to $16.36 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.7%. This historical growth can be attributed to an intensified focus on assessing vaccine efficacy, the broader application of immunotherapy in cancer care, heightened awareness regarding immune system health, the proliferation of global disease surveillance initiatives, increased investments in biopharmaceutical research and development, and a rising requirement for transplant compatibility evaluations.

The immune response testing market is projected to experience substantial expansion in the coming years, with its size forecast to reach $24.29 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.4%. This anticipated growth during the forecast period is primarily driven by the increasing incidence of emerging zoonotic diseases, a rising demand for at-home immune test kits, greater adoption of preventive healthcare practices, increased investments in pandemic preparedness, and an escalating need for transplant compatibility testing. Significant trends expected during this period include advancements in vaccine efficacy monitoring, sophisticated applications of AI in immune profiling, continued innovation in at-home immune test kits, the integration of immunotherapy in cancer treatment, and ongoing progress in transplant compatibility testing.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27314&type=smp

What Market Forces Are Contributing To The Growth Of The Immune Response Testing Market?

The increasing occurrence of autoimmune conditions is anticipated to fuel the expansion of the immune response testing market in the future. Autoimmune conditions are characterized by the body’s immune system mistakenly attacking its own healthy cells and tissues. The heightened prevalence of these diseases is mainly attributed to greater exposure to environmental contaminants, which can interfere with immune function and initiate immune attacks on the body’s own tissues. Immune response testing improves the management of autoimmune diseases by offering accurate information on the body’s immune activity, facilitating prompt diagnosis and tailored treatment strategies. This testing aids in enhanced disease surveillance and contributes to better patient results via adjustments in targeted therapies. For example, in November 2024, a survey conducted by Versorgungsatlas.de, a Germany-based organization, indicated that out of 73,241,305 insured individuals in 2022 (up from 68,959,472 in 2012), 6,304,340 received a diagnosis of at least one autoimmune disease, yielding a raw prevalence rate of 8.61%. Consequently, the growing incidence of autoimmune diseases is propelling the development of the immune response testing market.

Which Segmentation Factors Are Critical In The Immune Response Testing Market Analysis?

The immune response testing market covered in this report is segmented

1) By Type Of Testing: Antibody Testing, Cytokine Testing, Cellular Testing, Complement System Testing

2) By Application: Allergy Testing, Human Immunodeficiency Virus (HIV) Disease, Cancer, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Other Applications

3) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Antibody Testing: Immunoglobulin G (IgG) Testing, Immunoglobulin A (IgA) Testing, Immunoglobulin M (IgM) Testing, Neutralizing Antibody Testing, Rapid Antibody Testing

2) By Cytokine Testing: Enzyme-Linked Immunosorbent Assay (ELISA)-Based Cytokine Assays, Multiplex Cytokine Assays, Flow Cytometry-Based Cytokine Assays, Cytometric Bead Array, Quantitative Polymerase Chain Reaction (qPCR)-Based Cytokine Analysis

3) By Cellular Testing: T-Cell Response Assays, B-Cell Response Assays, Natural Killer (NK) Cell Assays, Lymphocyte Proliferation Assays, ELISpot Assays

4) By Complement System Testing: Total Hemolytic Complement (CH50) Assay, Alternative Pathway Hemolytic Complement (AH50) Assay, Complement Component 3 And 4 (C3 And C4) Complement Testing, Mannose-Binding Lectin (MBL) Testing, Complement Activity Assays

What Are The Dominant Trends Currently Seen In The Immune Response Testing Market?

Major companies operating in the immune response testing market are strategically developing advanced diagnostic solutions, such as automated immune response assays, to elevate accuracy, improve efficiency, and decrease turnaround times. These automated immune response assays represent sophisticated laboratory tests that measure the body’s immune activity, including antibody levels or cytokine profiles, with minimal manual intervention. For instance, in August 2022, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, introduced the Elecsys IGRA SARS-CoV-2 test. This innovative test is an automated interferon-gamma release assay (IGRA) specifically designed to detect T-cell immune responses to SARS-CoV-2, offering insights into long-term immunity beyond what antibody testing provides. The Elecsys IGRA test is run on Roche’s cobas e analyzers, enabling high-throughput testing with rapid results, which is essential for large-scale immune monitoring in both clinical and research environments. This advancement supports a more thorough understanding of vaccine efficacy and natural immunity, thereby assisting public health decision-making.

Which Organizations Are At The Forefront Of The Immune Response Testing Market?

Major companies operating in the immune response testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton Dickinson and Company, Quest Diagnostics Incorporated, Eurofins Scientific SE, PerkinElmer Inc., bioMérieux SA, Bruker Corporation, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin S.p.A., EUROIMMUN Medizinische Labor diagnostika AG, Myriad Genetics Inc., NanoString Technologies Inc., GenScript Biotech Corporation, Cell Signaling Technology Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/immune-response-testing-global-market-report

Which Region Is Leading Innovation In The Immune Response Testing Market?

North America was the largest region in the immune response testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immune response testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27314&type=smp

Browse Through More Reports Similar to the Global Immune Response Testing Market 2025, By The Business Research Company

Nanorobotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nanorobotics-global-market-report

Nanosilica Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nanosilica-global-market-report

Nanofibers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nanofibers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model